Search Results - "Bădeliță, Sorina"

Refine Results
  1. 1

    Cardiac amyloidosis is not a single disease: a multiparametric comparison between the light chain and transthyretin forms by Neculae, Gabriela, Adam, Robert, Jercan, Andreea, Bădeliță, Sorina, Tjahjadi, Catherina, Draghici, Mirela, Stan, Claudiu, Bax, Jeroen J., Popescu, Bogdan A., Marsan, Nina Ajmone, Coriu, Daniel, Jurcuț, Ruxandra

    Published in ESC Heart Failure (01-10-2024)
    “…Aims Systemic amyloidosis represents a heterogeneous group of diseases resulting from amyloid fibre deposition. The purpose of this study is to establish a…”
    Get full text
    Journal Article
  2. 2

    Complications of Brentuximab Therapy in Patients with Hodgkin's Lymphoma and Concurrent Autoimmune Pathology-A Case Series by Preda, Oana Diana, Bădeliță, Sorina, Ursuleac, Iulia, Irimia, Ruxandra Maria, Balanica, Sonia, Cojocaru, Monica, Cotruta, Cristina, Dobrea, Camelia, Coriu, Daniel

    Published in Hematology reports (20-05-2024)
    “…: Brentuximab Vedotin (BV) has revolutionized the treatment landscape for Hodgkin's lymphoma, yet its effects on pre-existing autoimmune disorders remain…”
    Get full text
    Journal Article
  3. 3

    Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature by Adam, Robert Daniel, Coriu, Daniel, Jercan, Andreea, Bădeliţă, Sorina, Popescu, Bogdan A., Damy, Thibaud, Jurcuţ, Ruxandra

    Published in ESC Heart Failure (01-08-2021)
    “…Cardiac amyloidosis is a restrictive cardiomyopathy determined by the accumulation of amyloid, which is represented by misfolded protein fragments in the…”
    Get full text
    Journal Article
  4. 4

    Evans Syndrome as a Possible Complication of Brentuximab Vedotin Therapy for Peripheral T Cell Lymphoma by Irimia, Ruxandra, Barbu, Sinziana, Popa, Codruta, Badelita, Sorina

    Published in Hematology reports (22-03-2023)
    “…Recently, Brentuximab Vedotin (BV) has emerged as an important therapy not only for Hodgkin's Lymphoma, but also for CD30-positive T cell lymphomas. Although…”
    Get full text
    Journal Article
  5. 5

    Real-World Use and Effectiveness of Carfilzomib Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma in Europe by Terpos, Evangelos, Zambello, Renato, Leleu, Xavier, Kuehr, Thomas, Badelita, Sorina N, Katodritou, Eirini, Brescianini, Alessandra, Liang, Tony, Wetten, Sally, Caers, Jo

    Published in Cancers (28-10-2022)
    “…This prospective, observational study examined the real-world use of carfilzomib across 11 European countries in adults with relapsed/refractory multiple…”
    Get full text
    Journal Article Web Resource
  6. 6

    Determining diagnostic delays in Romanian multiple myeloma patients using the Aarhus statement by Irimia, Ruxandra, Badelita, Sorina, Barbu, Sinziana, Cirlan, Ioana Loredana, Zidaru, Larisa, Coriu, Daniel

    Published in Frontiers in medicine (24-05-2024)
    “…Multiple Myeloma (MM) is classified as one of the most challenging cancers to diagnose, and the hematological malignancy is associated with prolonged…”
    Get full text
    Journal Article
  7. 7
  8. 8

    DNA Sequencing of CD138 Cell Population Reveals TP53 and RAS-MAPK Mutations in Multiple Myeloma at Diagnosis by Dragomir, Mihaela, Călugăru, Onda-Tabita, Popescu, Bogdan, Jardan, Cerasela, Jardan, Dumitru, Popescu, Monica, Aposteanu, Silvia, Bădeliță, Sorina, Nedelcu, Gabriela, Șerban, Cătălin, Popa, Codruța, Vassu-Dimov, Tatiana, Coriu, Daniel

    Published in Cancers (01-01-2024)
    “…Multiple myeloma is a hematologic neoplasm caused by abnormal proliferation of plasma cells. Sequencing studies suggest that plasma cell disorders are caused…”
    Get full text
    Journal Article
  9. 9

    Management of multiple myeloma patients with renal disease by ACHIM, Camelia, SIMSENSOHN, Eliza, BADELITA, Sorina, ZGURA, Anca, HAINEALA, Bogdan

    Published in Practica medicală (2006) (31-12-2021)
    “…Multiple myeloma (MM) is a plasma cell dyscrasia, accounting for 10% of all hematological malignancies, which translates into a global age-standardized…”
    Get full text
    Journal Article
  10. 10

    Real‐world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel by Leleu, Xavier, Katodritou, Eirini, Kuehr, Thomas, Terpos, Evangelos, Caers, Jo, Zambello, Renato, Brescianini, Alessandra, Liang, Tony, Wetten, Sally, Badelita, Sorina N.

    Published in EJHaem (01-02-2023)
    “…Clinical trials have demonstrated the efficacy and safety of carfilzomib in patients with relapsed/refractory multiple myeloma (RRMM); however, prospective…”
    Get full text
    Journal Article Web Resource
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    IgG,kappa monoclonal gammopathy of unknown significance with AL amyloidosis simulating giant cell arteritis by Pompilian, Valer Mihai, Tănăseanu, Ştefăniţă, Badea, Camelia, Zurac, Sabina, Socoliuc, Claudiu, Badelita, Sorina, Botez, Elena, Antohe, Mihaela

    Published in Revue roumaine de médecine interne (1990) (26-09-2017)
    “…Monoclonal gammopathies complicated by AL amyloidosis can mimic giant cell arteritis (GCA). We hereby present the case of a 63 year old woman in whom symptoms…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Diagnostic challenge in a patient with primary bilateral Dumbbell-shaped lumbar non-Hodgkin’s lymphoma by Adam, D., Burduşa, Gina, Iftimie, D., Hornea, Ioana, Dobrea, Camelia, Badelita, Sorina Nicoleta

    Published in Romanian neurosurgery (01-06-2016)
    “…: Primary bilateral dumbbell-shaped lumbar non-Hodgkin lymphomas with epidural and extraspinal involvement, are rare occurrences. Patients presenting at…”
    Get full text
    Journal Article
  19. 19
  20. 20